James Joshua Jackson - 24 Oct 2025 Form 4 Insider Report for Science Applications International Corp (SAIC)

Reporting relationship: EVP, Army
Issuer ticker: SAIC
Reported as of: 24 Oct 2025
Net transaction value: +$2,231
SEC form: 4
Accepted by SEC: 27 Oct 2025, 16:00:55 UTC
Prior SEC filing: 28 Jul 2025
Source filing: View source filing
Reporting owner signature: Hilary L. Hageman, Attorney-in-fact

Key filing fact

James Joshua Jackson filed Form 4 for Science Applications International Corp (SAIC) on 27 Oct 2025.

Key facts

This page summarizes James Joshua Jackson's Form 4 filing for Science Applications International Corp (SAIC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Oct 2025, 16:00.

Change

Previous filing in this sequence was filed on 28 Jul 2025.
Current net transaction value: +$2,231.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002008796 Primary reporting owner

Jackson James Joshua

Relationship: EVP, Army
Address: 12010 SUNSET HILLS ROAD, RESTON
Signature: Hilary L. Hageman, Attorney-in-fact
Signature date: 27 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SAIC transaction

Common Stock

Award

Transaction value: $2,231
Shares: +22
Change %: +0.35%
Price: $100.64
Shares after: 6,412
Date: 24 Oct 2025
Ownership: KESDP
Footnotes: F1

SAIC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 14,423
Date: 24 Oct 2025
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Additional restricted stock units awarded upon the deemed reinvestment of dividend equivalents.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .